These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26098709)

  • 41. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Soleymani T; Tyler Hollmig S
    Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myxoid atypical fibroxanthoma: a previously undescribed variant.
    Patton A; Page R; Googe PB; King R
    J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value.
    Monteagudo C; Calduch L; Navarro S; Joan-Figueroa A; Llombart-Bosch A
    Am J Clin Pathol; 2002 Jan; 117(1):126-31. PubMed ID: 11789717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atypical fibroxanthoma: new insights.
    Hussein MR
    Expert Rev Anticancer Ther; 2014 Sep; 14(9):1075-88. PubMed ID: 24958232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical fibroxanthoma-a diagnosis of exclusion!
    Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
    Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical fibroxanthoma with prominent sclerosis.
    Bruecks AK; Medlicott SA; Trotter MJ
    J Cutan Pathol; 2003 May; 30(5):336-9. PubMed ID: 12753176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma.
    Mentzel T; Calonje E; Fletcher CD
    Am J Surg Pathol; 1994 Mar; 18(3):258-65. PubMed ID: 8116793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous balloon cell dermatofibroma (fibrous histiocytoma).
    Tran TA; Hayner-Buchan A; Jones DM; McRorie D; Carlson JA
    Am J Dermatopathol; 2007 Apr; 29(2):197-200. PubMed ID: 17414448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reconsidering the diagnostic and prognostic utility of LN-2 for undifferentiated pleomorphic sarcoma and atypical fibroxanthoma.
    Hollmig ST; Rieger KE; Henderson MT; West RB; Sundram UN
    Am J Dermatopathol; 2013 Apr; 35(2):176-9. PubMed ID: 23000905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
    Ly H; Selva D; James CL; Huilgol SC
    Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pleomorphic Dermal Sarcoma.
    Saleh JS; Whittington CP; Bresler SC; Patel RM
    Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clear-cell atypical fibroxanthoma: an uncommon histopathologic variant of atypical fibroxanthoma.
    Requena L; Sangueza OP; Sánchez Yus E; Furio V
    J Cutan Pathol; 1997 Mar; 24(3):176-82. PubMed ID: 9085154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical fibroxanthoma: a histological and immunohistochemical review of 171 cases.
    Beer TW; Drury P; Heenan PJ
    Am J Dermatopathol; 2010 Aug; 32(6):533-40. PubMed ID: 20526171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical fibroxanthoma/malignant fibrous histiocytoma.
    Marcet S
    Dermatol Ther; 2008; 21(6):424-7. PubMed ID: 19076618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
    Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
    Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas.
    Prieto VG; Reed JA; Shea CR
    J Cutan Pathol; 1995 Aug; 22(4):336-41. PubMed ID: 7499573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prominent myofibroblastic differentiation. A pitfall in the diagnosis of dermatofibroma.
    Zelger BW; Zelger BG; Rappersberger K
    Am J Dermatopathol; 1997 Apr; 19(2):138-46. PubMed ID: 9129698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall.
    Doyle LA; Fletcher CD
    J Cutan Pathol; 2011 Sep; 38(9):697-703. PubMed ID: 21752057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of Epithelial to Mesenchymal Transition in Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma to Discern an Epithelial Origin.
    Toll A; Gimeno J; Baró T; Hernández-Muñoz MI; Pujol RM
    Am J Dermatopathol; 2016 Apr; 38(4):270-7. PubMed ID: 26999338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutaneous Atypical Fibroxanthoma With Osteoclast-Like Giant Cell: A Rare but Diagnostic Pitfall.
    Shaker N; Phelps R; Niedt G; Patel A; Wu D; Aung PP; Prieto V; Church A; Pradhan D
    Am J Dermatopathol; 2023 Oct; 45(10):704-707. PubMed ID: 37708369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.